Nuvectis Pharma, Inc. — Director's Dealing 2025

Feb 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-02-07

Reporting Person: Mosseri Marlio Charles (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-07	Common Stock	P	240000	$5.00	Acquired	2884121	Indirect

Footnotes

F1: Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.